Peptide stability: why peptides degrade and how to prevent it
Hydrolysis, oxidation, aggregation, contamination — why research peptides degrade, and the handling habits that slow each pathway down.
Peptides are precise molecules, and that precision is fragile. In the wrong conditions a peptide loses the exact structure that makes it useful — so understanding why they degrade, and how to slow it, is part of reproducible research.
What degradation means
A peptide is a defined sequence arranged in a specific way. Degradation is any chemical or physical change that moves it away from that state: a broken bond, an altered side chain, or molecules clumping together. The material then no longer matches its certificate of analysis.
The main degradation pathways
Several routes are described in the research literature. Hydrolysis is the breaking of peptide bonds by water, so moisture is a risk. Oxidation alters sensitive amino acids on exposure to air or light. Aggregation is peptides clumping together under heat or agitation. Microbial contamination enters a solution through repeated punctures.
Why the lyophilised form is more stable
Research-grade peptides ship and store as a lyophilised (freeze-dried) powder for this reason. With water removed, hydrolysis and microbial growth slow dramatically, so the dry form is kept until a peptide is actually needed.
How to slow degradation
Keep vials cold, dry and out of the light, and let a cold vial reach room temperature before opening so condensation does not draw moisture in. Reconstitute with bacteriostatic water, whose preservative lets a multi-use vial tolerate repeated punctures; swirl gently rather than shaking; and aliquot to avoid repeated freeze–thaw cycles. Our reconstitution guide covers the method.
The role of documentation
A certificate of analysis describes a peptide at the moment it was tested; careful handling is what keeps the material matching that document. Every Vela batch ships with one, issued within six months of sale.
Keep reading
More from the
research bench.
Retatrutide: the triple agonist explained
One molecule, three receptor pathways. Why retatrutide is one of the most closely watched compounds in modern metabolic research.
Tirzepatide: the dual GIP/GLP-1 agonist
How engaging two incretin pathways at once set tirzepatide apart, and what researchers study it for.
Why modified peptides last longer: half-life and modifications
How amino-acid substitutions, fatty-acid chains and added size extend a peptide's half-life, and why it matters in research.
